For research use only. Not for therapeutic Use.
Spartalizumab (anti-PD-1) is a humanized anti-PD-1 IgG4 antibody that blocks the binding of PD-L1 and PD-L2 to PD-1. It binds to PD-1 with high affinity and inhibits the biological activity of PD-1, MW: 145.8 KD.
| Catalog Number | I047470 |
| Purity | ≥95% |
| Reference | [1] J. Vansteenkiste, et al. Journal of Thoracic Oncology. 2017, 12(11):suppl2, S2402. |
